Cadence Bank NA’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,842
Closed -$359K 177
2018
Q2
$359K Buy
+2,842
New +$346K 0.15% 129
2018
Q1
Sell
-2,890
Closed -$317K 163
2017
Q4
$317K Hold
2,890
0.12% 138
2017
Q3
$285K Hold
2,890
0.11% 149
2017
Q2
$293K Hold
2,890
0.13% 110
2017
Q1
$334K Hold
2,890
0.15% 97
2016
Q4
$347K Hold
2,890
0.16% 96
2016
Q3
$325K Hold
2,890
0.15% 93
2016
Q2
$358K Hold
2,890
0.18% 92
2016
Q1
$325K Sell
2,890
-955
-25% -$99.2K 0.17% 97
2015
Q4
$418K Hold
3,845
0.22% 86
2015
Q3
$384K Hold
3,845
0.22% 88
2015
Q2
$438K Sell
3,845
-965
-20% -$117K 0.28% 65
2015
Q1
$503K Sell
4,810
-755
-14% -$80.4K 0.28% 78
2014
Q4
$670K Hold
5,565
0.36% 59
2014
Q3
$814K Hold
5,565
0.44% 44
2014
Q2
$930K Hold
5,565
0.5% 35
2014
Q1
$1.1M Sell
5,565
-1,525
-22% -$288K 0.66% 28
2013
Q4
$1.35M Hold
7,090
0.74% 23
2013
Q3
$1.2M Sell
7,090
-1,250
-15% -$194K 0.72% 23
2013
Q2
$1.26M Buy
+8,340
New +$1.18M 0.69% 25

Other funds holding CLB

Cadence Bank NA's CLB Position: Q3 2018 in Review

Cadence Bank NA sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 2,842 shares — an estimated $359K sold.

Cadence Bank NA first reported a position in CLB in Q2 2013 and held it in 20 quarters. The position peaked at $1.35M in Q4 2013. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

  • Cadence Bank NA reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
  • Cadence Bank NA sold 2,842 Core Laboratories shares in Q3 2018, an estimated $359K.
  • Cadence Bank NA first reported a position in Core Laboratories in Q2 2013 and held it in 20 quarters.
  • Cadence Bank NA's Core Laboratories position peaked at $1.35M in Q4 2013.
  • 359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Cadence Bank NA's 13F filing for Q3 2018, filed 6 Nov 2018.